b'Elevating the standard of carewith a broad portfolio of innovative wound care solutionsUsing our advanced wound care product portfolio1 INTERVENEON DAY 1 to manage bioburden and prevent biofilm re-formation for all wound types*plus sharp debridement 2 ASSESSAT WEEK 4 to evaluateContinue or switch surface area reduction3 DECIDEto use PuraPly AM,PuraPly XT Extra Fenestrated,AllApligraf, Affinity, Novachor,wounds*or NuShieldOnly DFUs and VLUsAllwoundsAllwounds*PuraPly AM and PuraPly XT Extra Fenestrated are not indicated for use in third-degree burns.Organogenesis is a leader in wound healing and for over 20 yearshas provided innovative solutions to help empower clinicians.Our portfolio of advanced skin substitutes helps support woundhealingfrom acute to chronic, head to toe, and start to finish.Visit Organogenesis.com to learn more2021 Organogenesis Inc. OI-AWCP110311/2023 All rights reserved. Printed in U.S.A.Affinity, NuShield, PuraPly, PuraPly AM, and PuraPly XT are registered trademarksof Organogenesis Inc. Novachor is a trademark of Organogenesis Inc.Apligraf is a registered trademark of Novartis. 23226_Portfolio Print Ad_M.indd 1 12/1/21 10:55 AM'